Attached to the stomach in a minimally invasive procedure, the Israeli-innovated device frees diabetics from pills and injections.
Israeli medical device company MetaCure is beginning to commercialize its innovative minimally invasive solution, DIAMOND, which received the European Union’s CE mark in 2007 and is undergoing additional clinical trials.
An implantable gastric stimulator with electrodes attached through laparoscopic surgery to the outer stomach muscles, DIAMOND enhances stomach muscle contractions, which are the natural physiological response to eating. This causes the patient to feel full more quickly during a meal. It also affects the gastrointestinal (GI) system’s release of hormones influencing hunger, satiety and the absorption and metabolism of nutrients.
Categories: Alternative Medicine, Israel, Science and Technology